Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma

NCT02054130 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02054130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
December 13, 2013
Completion date
March 1, 2017
Enrollment
584 (actual)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

asthma